Clinical Trials Browser

Phase 2 × Liver Neoplasms × Irinotecan × Clear all

NCT00287976 2013-09-17

Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms, Hepatoblastoma

NCT00087282 2013-06-24

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms